Anti-IL1 in patients with low penetrance mutations for autoinflammatory diseases: tuscany and sicilian case series from paediatric to adult age

Risultato della ricerca: Meeting Abstract

Abstract

Patients with low penetrance mutations for Autoinflammatory syndromes (AID) can have severe clinical manifestations, which require to be treated with biological drugs anti-IL-1. Objectives: To evaluate the response of AID to treatment with the recombinant human IL-1 receptor antagonist anakinra or with the anti-IL-1b.
Lingua originaleEnglish
pagine (da-a)104-104
Numero di pagine1
RivistaPEDIATRIC RHEUMATOLOGY ONLINE JOURNAL
Volume15
Stato di pubblicazionePublished - 2017

Fingerprint Entra nei temi di ricerca di 'Anti-IL1 in patients with low penetrance mutations for autoinflammatory diseases: tuscany and sicilian case series from paediatric to adult age'. Insieme formano una fingerprint unica.

  • Cita questo